Anti-Myosin Phosphatase antibody
Be the first to review this product! Submit a review
|
(11 Publications)
Rabbit Polyclonal Myosin Phosphatase antibody. Suitable for WB, IHC-P and reacts with Mouse, Human samples. Cited in 11 publications. Immunogen corresponding to Synthetic Peptide within Human PPP1R12A.
View Alternative Names
MBS, MYPT1, PPP1R12A, Protein phosphatase 1 regulatory subunit 12A, Myosin phosphatase-targeting subunit 1, Protein phosphatase myosin-binding subunit, Myosin phosphatase target subunit 1
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Myosin Phosphatase antibody (AB59235)
ab59235 at 1/50 dilution staining Myosin Phosphatase in human brain by Immunohistochemistry, Paraffin embedded tissue, in the absence or presence of the immunising peptide.
- WB
Unknown
Western blot - Anti-Myosin Phosphatase antibody (AB59235)
All lanes:
Western blot - Anti-Myosin Phosphatase antibody (ab59235) at 1/500 dilution
Lane 1:
NIH3T3 cell extract
Lane 2:
NIH3T3 cell extract with immunising peptide
Predicted band size: 115 kDa
Observed band size: 130 kDa
false
- WB
CiteAb
Western blot - Anti-Myosin Phosphatase antibody (AB59235)
Myosin Phosphatase western blot using anti-Myosin Phosphatase antibody ab59235. Publication image and figure legend from Montalvo, J., Spencer, C., et al., 2013, Curr Mol Med, PubMed 22934846.
ab59235 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab59235 please see the product overview.
ROCK1 & 2 display paralog specific cytoskeletal control in endothelial cells. (A) Growth patterns of confluent monolayers of MS1 endothelial cells stably expressing either non-targeting control, ROCK1, or ROCK2 shRNA expression vectors, or non-targeting control shRNA MS1 cells treated with 10 μM Y27632. (B) MS1 endothelial cells stably expressing non-targeting control, ROCK1, or ROCK2 shRNA expression vectors, and control shRNA MS1 cells treated with 10 μM Y27632 were grown on glass coverslips for 24 hours. Actin microfilaments in each condition were visualized by rhodamine-conjugated phalloidin staining while nuclei were counterstained with DAPI. Immunofluorescent images were captured with scanning confocal microscopy. (solid arrows=areas of cell retraction; a=control shRNA, b=Y27632, c= ROCK1 shRNA, d=ROCK2 shRNA) (C) Semi-quantitative RT-PCR analysis of actin alpha 1 (Acta1), actin alpha 2 (Acta2), and Gapdh steady state mRNA expression levels. (D) Western blot detection of the phosphorylated (p) and total (t) forms of the myosin binding subunit of myosin phosphatase (MBS), cofilin, and ezrin/radixin/moesin (ERM). Ponceau staining of the membrane was used as a loading control. (E) Quantification of the normalized levels of phosphorylated MBS, cofilin, and ERM phosphorylation in each condition. (C=control shRNA, R1=ROCK1 shRNA, R2=ROCK2 shRNA, Y=Y27632; * indicates p<0.05)
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Myosin phosphatase regulates contraction by reversing phosphorylation of myosin light chains an important process in muscle function and various cellular activities. This enzyme operates as part of the myosin phosphatase complex where it provides the capability needed to maintain equilibrium between phosphorylating and dephosphorylating processes. By controlling this balance myosin phosphatase plays a significant role in cell movement cell shape and tension maintenance.
Pathways
Myosin phosphatase is integrated into the RhoA/Rho-kinase signaling pathway which is important for cytoskeletal dynamics and cell adhesion. Within this pathway myosin phosphatase interacts with proteins like Rho-kinase (ROCK) which counter-regulates its activity by inhibiting dephosphorylation. The crosstalk with another protein protein phosphatase 1 is also significant in controlling phosphorylation states and facilitating cellular responses to external stimuli.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in molecular biosciences 12:1636882 PubMed40880987
2025
Applications
Unspecified application
Species
Unspecified reactive species
Lung 203:39 PubMed40047936
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer science 112:2739-2752 PubMed33939241
2021
Applications
Unspecified application
Species
Unspecified reactive species
Medicine 99:e20060 PubMed32664054
2020
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 9:539 PubMed31316912
2019
Applications
Unspecified application
Species
Unspecified reactive species
Pathology, research and practice 215:152464 PubMed31176575
2019
Applications
Unspecified application
Species
Unspecified reactive species
Current molecular medicine 18:100-108 PubMed29974831
2018
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 14:2221-2227 PubMed28962146
2017
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 14:308-316 PubMed28672931
2017
Applications
Unspecified application
Species
Unspecified reactive species
Current molecular medicine 13:205-19 PubMed22934846
2012
Applications
WB
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com